152 related articles for article (PubMed ID: 8250815)
1. A novel endothelial cell molecule mediating lymphocyte binding in humans.
Jalkanen S; Salmi M
Behring Inst Mitt; 1993 Aug; (92):36-43. PubMed ID: 8250815
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).
Arvilommi AM; Salmi M; Kalimo K; Jalkanen S
Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974
[TBL] [Abstract][Full Text] [Related]
3. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.
Salmi M; Jalkanen S
Eur J Immunol; 1995 Oct; 25(10):2803-12. PubMed ID: 7589075
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium.
Airas L; Salmi M; Jalkanen S
J Immunol; 1993 Oct; 151(8):4228-38. PubMed ID: 8409398
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
Bono P; Salmi M; Smith DJ; Jalkanen S
J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
[TBL] [Abstract][Full Text] [Related]
6. The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes.
Nakache M; Berg EL; Streeter PR; Butcher EC
Nature; 1989 Jan; 337(6203):179-81. PubMed ID: 2911352
[TBL] [Abstract][Full Text] [Related]
7. Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion.
Salmi M; Rajala P; Jalkanen S
J Clin Invest; 1997 May; 99(9):2165-72. PubMed ID: 9151788
[TBL] [Abstract][Full Text] [Related]
8. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes.
Salmi M; Hellman J; Jalkanen S
J Immunol; 1998 Jun; 160(11):5629-36. PubMed ID: 9605169
[TBL] [Abstract][Full Text] [Related]
9. The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium.
van Dinther-Janssen AC; Horst E; Koopman G; Newmann W; Scheper RJ; Meijer CJ; Pals ST
J Immunol; 1991 Dec; 147(12):4207-10. PubMed ID: 1721640
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion.
Spertini O; Luscinskas FW; Kansas GS; Munro JM; Griffin JD; Gimbrone MA; Tedder TF
J Immunol; 1991 Oct; 147(8):2565-73. PubMed ID: 1717567
[TBL] [Abstract][Full Text] [Related]
11. Organ-selective regulation of vascular adhesion protein-1 expression in man.
Arvilommi AM; Salmi M; Jalkanen S
Eur J Immunol; 1997 Jul; 27(7):1794-800. PubMed ID: 9247594
[TBL] [Abstract][Full Text] [Related]
12. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans.
Salmi M; Jalkanen S
Science; 1992 Sep; 257(5075):1407-9. PubMed ID: 1529341
[TBL] [Abstract][Full Text] [Related]
13. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
[TBL] [Abstract][Full Text] [Related]
14. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
15. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells.
Salmi M; Jalkanen S
J Exp Med; 1996 Feb; 183(2):569-79. PubMed ID: 8627168
[TBL] [Abstract][Full Text] [Related]
16. [Vascular adhesion protein-1 (VAP-1) in inflammatory process].
Pietruczuk M; Pietruczuk A; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
Przegl Lek; 2006; 63(4):220-2. PubMed ID: 17083159
[TBL] [Abstract][Full Text] [Related]
17. Induction and function of vascular adhesion protein-1 at sites of inflammation.
Salmi M; Kalimo K; Jalkanen S
J Exp Med; 1993 Dec; 178(6):2255-60. PubMed ID: 8245796
[TBL] [Abstract][Full Text] [Related]
18. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
[TBL] [Abstract][Full Text] [Related]
19. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear.
Salmi M; Tohka S; Jalkanen S
Circ Res; 2000 Jun; 86(12):1245-51. PubMed ID: 10864915
[TBL] [Abstract][Full Text] [Related]
20. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma.
Yoong KF; McNab G; Hübscher SG; Adams DH
J Immunol; 1998 Apr; 160(8):3978-88. PubMed ID: 9558106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
